UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000034235
Receipt number R000039023
Scientific Title Establishment of computer-assisted diagnosis support system as an artificial intelligence function for management of ulcerative colitis using endocytoscopy
Date of disclosure of the study information 2018/09/21
Last modified on 2021/09/02 17:51:01

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Establishment of computer-assisted diagnosis support system as an artificial intelligence function for management of ulcerative colitis using endocytoscopy

Acronym

UC-CAD study

Scientific Title

Establishment of computer-assisted diagnosis support system as an artificial intelligence function for management of ulcerative colitis using endocytoscopy

Scientific Title:Acronym

UC-CAD study

Region

Japan


Condition

Condition

Ulcerative colitis

Classification by specialty

Gastroenterology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To establish a computer-assisted diagnosis support system as an artificial intelligence function for management of ulcerative colitis using endocytoscopy, and evaluate the efficacy of AI system.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

a computer-assisted diagnosis support system as an artificial intelligence function to predict endoscopic pathological healing

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Other

Interventions/Control_1

When observe using endocytoscope(NBI), take a biopsy

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

eligible patients
>who were diagnosed with Ulcerative Colitis,
>who need lower GI observation in their clinical coarse,
>who are 20 years of age or more

Key exclusion criteria

Patients are excluded if
>they have a history of radiation therapy to their abdomen,
>it is impossible to take a biopsy because of the blood disorders or under anticoagulant therapy,
>they reject to join this clinical study.

Target sample size

850


Research contact person

Name of lead principal investigator

1st name Haruhiko
Middle name
Last name Ogata

Organization

Keio University Schoool of Medicine

Division name

Center for Diagnostic and Therapeutic Endoscopy

Zip code

1608582

Address

35 Shinanomachi Shinjuku-ku, Tokyo

TEL

03-3353-1211

Email

hogata@z8.keio.jp


Public contact

Name of contact person

1st name Makoto
Middle name
Last name Mutaguchi

Organization

Keio University Schoool of Medicine

Division name

Center for Diagnostic and Therapeutic Endoscopy

Zip code

1608582

Address

35 Shinanomachi Shinjuku-ku, Tokyo

TEL

03-3353-1211

Homepage URL


Email

ma.mutaguchi@gmail.com


Sponsor or person

Institute

Keio University Schoool of Medicine

Institute

Department

Personal name



Funding Source

Organization

Keio University Schoool of Medicine, Center for Diagnostic and Therapeutic Endoscopy

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor

Syowa University Northern Yokohama Hospital
National University Corporation Tokyo Medical and Dental University
Nagoya university

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Keio University School of Medicine Ethics Review Committee

Address

35 Shinanomachi Shinjuku-ku, Tokyo

Tel

0333531211

Email

ma.mutaguchi@gmail.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

昭和大学横浜市北部病院
東京医科歯科大学医学部附属病院
名古屋大学


Other administrative information

Date of disclosure of the study information

2018 Year 09 Month 21 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2018 Year 02 Month 23 Day

Date of IRB

2018 Year 06 Month 05 Day

Anticipated trial start date

2018 Year 02 Month 23 Day

Last follow-up date

2021 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 09 Month 21 Day

Last modified on

2021 Year 09 Month 02 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000039023


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name